Sleep Research and Treatment Center, Department of Psychiatry and Behavioral Health, Penn State Health Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania.
Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin.
J Clin Sleep Med. 2021 Nov 1;17(11):2249-2256. doi: 10.5664/jcsm.9426.
The Hypersomnia Severity Index (HSI) was designed to assess the severity and impairment of hypersomnolence and has been validated in persons with psychiatric disorders. Little is known about its psychometric properties in clinical samples of patients with sleep disorders.
One hundred fifty-eight patients (aged 44.1 ± 16.4 years, 29.1% male, 19.6% racial/ethnic minority) evaluated at the Behavioral Sleep Medicine program of the Penn State Health Sleep Research and Treatment Center completed the HSI and other patient-reported outcomes. We examined the HSI's reliability and factorial, construct, and criterion validity.
The HSI showed satisfactory internal consistency (α = 0.79). A 2-factor structure, reflecting symptoms (HSI-S) and impairment, explained 56.2% of the variance. Convergent validity with the Epworth Sleepiness Scale was optimal ( = .65) but greater for HSI-S ( = .69) than for impairment ( = .39). Divergent validity was optimal for HSI-S against unrelated measures of sleep effort, reactivity, and incompatible behaviors ( ≤ .02). Construct validity showed higher scores in patients with central disorders of hypersomnolence and lower scores in patients with chronic insomnia disorder compared to those with other sleep disorders; however, these divergent scores were primarily driven by HSI-S rather than impairment. Criterion validity showed that an HSI-S cutoff score ≥ 8 provided the best balance in sensitivity/specificity (0.82/0.78) to identify central disorders of hypersomnolence (area under the curve, 0.85).
The HSI shows satisfactory indices of reliability and validity in a clinical patient sample. Its construct and criterion validity are supported by its divergent association with other patient-reported outcomes and central disorders of hypersomnolence vs chronic insomnia disorder diagnoses and the adequate sensitivity/specificity of its HSI-S cutoff score to reliably identify central disorders of hypersomnolence.
Fernandez-Mendoza J, Puzino K, Amatrudo G, et al. The Hypersomnia Severity Index: reliability, construct, and criterion validity in a clinical sample with sleep disorders. 2021;17(11):2249-2256.
嗜睡严重程度指数(HSI)旨在评估嗜睡的严重程度和障碍,并已在精神障碍患者中得到验证。然而,对于该指数在睡眠障碍患者的临床样本中的心理测量特性,我们知之甚少。
在宾夕法尼亚州立大学健康睡眠研究和治疗中心的行为睡眠医学项目中接受评估的 158 名患者(年龄 44.1±16.4 岁,29.1%为男性,19.6%为少数族裔)完成了 HSI 及其他患者报告的结果。我们检验了 HSI 的信度、因子结构、建构效度和效标效度。
HSI 表现出令人满意的内部一致性(α=0.79)。反映症状(HSI-S)和障碍的 2 因素结构解释了 56.2%的方差。与 Epworth 嗜睡量表的相关性最佳(r=0.65),但 HSI-S(r=0.69)的相关性优于障碍(r=0.39)。与睡眠努力、反应性和不兼容行为等不相关测量的区分效度最佳(r≤0.02)。与其他睡眠障碍相比,中枢性嗜睡障碍患者的 HSI-S 得分较高,而慢性失眠障碍患者的 HSI-S 得分较低;然而,这些发散性评分主要是由 HSI-S 而非障碍驱动的。效标效度表明,HSI-S 得分≥8 可提供最佳的敏感性/特异性(0.82/0.78),以识别中枢性嗜睡障碍(曲线下面积,0.85)。
HSI 在临床患者样本中表现出令人满意的信度和效度指标。其结构和效标效度得到了与其他患者报告的结果以及中枢性嗜睡障碍与慢性失眠障碍诊断的发散性关联的支持,以及其 HSI-S 得分的适当敏感性/特异性,可以可靠地识别中枢性嗜睡障碍。